Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso. - Wikidata - awgldk - TriplyDB

Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.

Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.

http://www.wikidata.org/entity/Q41912859

about

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]Rationale for short course primaquine in Africa to interrupt malaria transmission Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso Parallel screening of wild-type and drug-resistant targets for anti-resistance neuraminidase inhibitors A high susceptibility to redox imbalance of the transmissible stages of Plasmodium falciparum revealed with a luciferase-based mature gametocyte assay Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.PharmGKB summary: very important pharmacogene information for G6PD.Analyzing Thiol-Dependent Redox Networks in the Presence of Methylene Blue and Other Antimalarial Agents with RT-PCR-Supported in silico Modeling.Diagnosis of red cell G6PD deficiency in rural Burkina Faso: comparison of a rapid fluorescent enzyme test on filter paper with polymerase chain reaction based genotyping.In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya.PharmGKB summary: methylene blue pathway.Effect of chloroquine, methylene blue and artemether on red cell and hepatic antioxidant defence system in mice infected with Plasmodium yoelii nigeriensis.Efficacy of eosin B as a new antimalarial drug in a murine model.The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine.In vitro activity of Proveblue (methylene blue) on Plasmodium falciparum strains resistant to standard antimalarial drugs.Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs.Revisiting the physiological effects of methylene blue as a treatment of cyanide intoxication.Glucose-6-phosphate dehydrogenase deficiency and safety of methylene blue.Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.

P2860

Q21033481-40F62849-7DA2-4F4F-B24C-D2B8BCBDE869 Q21562479-B75FBD21-A4D9-479A-AC5D-CE94950AC0FD Q24815501-BE70548C-848E-4454-B3D4-3A857E66CFF2 Q27006552-BB534E93-0A83-4CD5-B446-DBCB9B0250E3 Q28472182-33587E66-F331-4AF1-BC4C-14CCC0BE5A9B Q28486252-8537E20F-2A66-4483-991E-9E7FD5562E4D Q30044470-285E743E-472F-4918-8333-315EEA30F9F0 Q35701564-FA92A6BA-24AB-42B5-A273-220A9FA96D03 Q36055205-7825210E-29D0-4C1B-AE7F-7F4413C0F46C Q36450015-8467F5D6-B55C-421F-9C81-AB864899050B Q39242193-408686F0-5128-4561-BA15-BB51BFF4E669 Q39610759-E5F06F0F-65DC-4205-8908-1B6DC665F22B Q40600918-5A0C7543-7101-480C-AFAC-B68260405048 Q41890556-5FF89E75-A877-4F16-BFFB-163023DA5560 Q41926000-C0C8DA79-8D0A-4736-A268-C0D6D7FFB235 Q41926931-D940B8C9-66C9-4C67-8BC1-5D77BCD10AAC Q41928320-E0F9B77B-11DC-4508-97A1-5307626553C5 Q41933403-5A32D048-91EA-4200-90AD-D3DA5E9D17DA Q43923789-9F703AA2-7BFC-4772-8174-7D605EC001DE Q43929062-9A63B898-5B75-4C4D-A571-F0E1C5097914 Q49943303-528AA128-1C13-47D3-89CA-4D145A856607 Q50263615-CD65A005-7BAC-4B60-864E-1DBC859949CA Q53696257-40AD919F-BFBB-4B26-A056-BBD4954FDFC5

P2860

Safety of the combination of chloroquine and methylene blue in healthy adult men with G6PD deficiency from rural Burkina Faso.

http://www.wikidata.org/entity/Q41912859

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Safety of the combination of c ...... iency from rural Burkina Faso.

@en

type

label

Safety of the combination of c ...... iency from rural Burkina Faso.

@en

prefLabel

Safety of the combination of c ...... iency from rural Burkina Faso.

@en

P1433

Q41912859-2EF99267-C56E-47B8-B26A-B11F0E02E02C

P1476

Q41912859-2B4D627E-E52A-46F8-8124-94951F98C458

P2093

Q41912859-0AF75691-B681-405D-8E19-07A08209CD93

Q41912859-15DD6F47-571E-4385-A6F0-51D6D01FAB16

Q41912859-38BE168D-C827-496F-A4EF-63BEFCBB9315

Q41912859-3E2967DD-96CB-420C-BB83-1E8DFFA8BB4A

Q41912859-41CBD4FC-6B0B-41F4-862C-6629F59745D4

Q41912859-79D12953-C0C7-4D97-802F-B2E0DB7D8D5D

Q41912859-7E6FCA63-890D-4E62-B6A6-4296D20D2A4F

Q41912859-B27ED089-742E-450F-A4E3-4F39847368C9

Q41912859-B519352A-618D-4AE4-9DD7-4CFD1697725B

Q41912859-B9FB784D-CA2A-4C76-83D4-DBE2EA68197C

P2860

Q41912859-0CF862AC-0CDC-40C2-8778-2E6165EF1727

Q41912859-13DF58D4-D039-4EC7-B7C6-F81E7721D91E

Q41912859-150DA3B3-AFA2-4024-8F52-DDCAD92D615D

Q41912859-29081D26-CACC-4F60-BFE0-F78E52C532DC

Q41912859-5000DAD7-36D9-4475-8442-436766D04FB4

Q41912859-586FFF74-1970-4DC0-B40E-5081F6FDC3BE

Q41912859-5BA3E8A5-DD26-418C-B57A-5404CE60744F

Q41912859-676E32AE-FD83-4242-8EFB-5FEA42C13803

Q41912859-74D3EA2B-C8E9-48DA-B7CF-022B9838258C

Q41912859-7E37E74F-844B-4AD5-9ECF-9B699A7E2EBB

P304

Q41912859-D9C08A20-6687-481C-8B8E-CC2C8E808294

P31

Q41912859-53E26CBD-8E5A-413B-B433-0FA459429B04

P356

Q41912859-E9FC3CA5-1E95-47E0-9FA6-F7927BEA9C48

P433

Q41912859-EE83AB12-A40A-4760-B555-974755330A59

P478

Q41912859-9DA0EE64-BD47-4D12-AA70-03392B360DF9

P50

Q41912859-111B3946-C6A3-4FA5-A1E6-93327E81E860

Q41912859-D40A27BB-972B-4955-92D5-C3B32BBA5E65

P577

Q41912859-5F662552-2150-412E-97AA-23CC75EF4644

P5875

Q41912859-35A41B7C-E98E-4991-A389-6722D8D5DB28

P698

Q41912859-2C468205-212F-4496-925F-BBEA1DD2DE40

P921

Q41912859-11A43718-B9A1-4AD9-A2FB-880058771192

Q41912859-614EE8FD-2073-4B9E-9E34-F6EDC56BEECF

P356

J.1365-3156.2004.01356.X

P1433

Tropical Medicine and International Health

P1476

Safety of the combination of c ...... iency from rural Burkina Faso.

@en

P2093

Albrecht Jahn

http://www.w3.org/2001/XMLSchema#string

Bocar Kouyaté

http://www.w3.org/2001/XMLSchema#string

Boubacar Coulibaly

http://www.w3.org/2001/XMLSchema#string

Germain Mandi

http://www.w3.org/2001/XMLSchema#string

Heiner Schirmer

http://www.w3.org/2001/XMLSchema#string

Ingeborg Walter-Sack

http://www.w3.org/2001/XMLSchema#string

Jens Rengelshausen

http://www.w3.org/2001/XMLSchema#string

Kirsten Wüst

http://www.w3.org/2001/XMLSchema#string

Klaus-Dieter Riedel

http://www.w3.org/2001/XMLSchema#string

Mamadou Sanon

http://www.w3.org/2001/XMLSchema#string

P2860

Malaria in 2002

The development of Lapdap, an affordable new treatment for malaria

Methylene blue as an antimalarial agent.

Phenothiazines: potential alternatives for the management of antibiotic resistant infections of tuberculosis and malaria in developing countries.

Modern chemotherapeutic options for malaria.

Effect of zinc supplementation on malaria and other causes of morbidity in west African children: randomised double blind placebo controlled trial.

Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.

Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue.

Averting a malaria disaster.

Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.

P304

32-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-3156.2004.01356.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jürgen Burhenne

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8076472

http://www.w3.org/2001/XMLSchema#string

P698

15655011

http://www.w3.org/2001/XMLSchema#string

P921